Historial de carrera de Heng Xie
Antiguos cargos conocidos de Heng Xie.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 01/03/2022 | 01/06/2022 |
| Secretario Corporativo | 01/06/2022 | - |
Formación de Heng Xie.
| The University of Alabama at Birmingham | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 2 |
| China | 2 |
Operativa
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Corporate Secretary | 1 |
Sectorial
| Consumer Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Bolsa de valores
- Insiders
- Heng Xie
- Experiencia
